The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
EDCTP opened new calls for research proposals under its second programme: diagnostic tools for poverty-related diseases; maximising the impact of EDCTP research; strategic projects with major cofunding; improved treatment; and clinical management of poverty-related diseases.
EDCTP is a partnership between Europa and sub-Saharan Africa, a partnership between 13 African and 13 European countries that jointly contribute to the fight against HIV/Aids, tuberculosis, malaria and other neglected infectious diseases.
Find out more about who we are!
EDCTP2 aims to contribute to the reduction of the social and economic burden of poverty-related diseases (PRDs) in developing countries, in particular in sub-Saharan Africa, by accelerating the clinical development of effective, safe, accessible, suitable and affordable medical interventions for PRDs in partnership with sub-Saharan Africa.
Calls for Proposals: ‘Strategic projects with major cofunding’ and ‘Improved treatment and clinical management of poverty-related diseases’
Today, EDCTP published two new calls for proposals under its second programme. The call Strategic projects with major cofunding aims…
EC Commissioner Carlos Moedas and Gulbenkian Foundation sign collaboration memorandum
This coincides with the prepublication today of an EDCTP 2015 Call for proposals aimed at strengthening the ethics and regulatory capacity in sub-Saharan Africa….